Molecular targeting therapy for gastric cancer / 医学研究生学报
Journal of Medical Postgraduates
;
(12): 1318-1322, 2014.
Article
in Chinese
| WPRIM
| ID: wpr-458019
ABSTRACT
Gastric cancer is the fifth most common cancer and the third leading cause of death globally .Apart from the suc-cessful phase Ⅲclinical trial of trastuzumab and Ramucirumab , other targeted therapies in gastric cancer ( GC) have fallen short or still in early clinical development .In this review, we will summarize the most up to date information on many of the potential actionabledriver genesin gastric cancer and the importance of using the optimal diagnostic test to select for these molecularly defined patients . We focus on the following aspectsHER-2, EGFR, FGFR, MET, IGF-1R and VEGF.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Medical Postgraduates
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS